ResearcherJiangsu Province HospitalActive in the last 2 years

Ying Ding

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0001-5581-3058; OpenAlex author ID A5005323080.

Their work

Papers: 3 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 3

Prognostic and Immunological Value of CTNNB1 in Pancreatic Adenocarcinoma: A Comprehensive NGS and Multicomponent Analysis. Last author DOI 10.1155/genr/8700258 ↗
REG3A secreted by peritumoral acinar cells enhances pancreatic ductal adenocarcinoma progression via activation of EGFR signaling. Last author DOI 10.1186/s12964-025-02103-4 ↗
Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating miR-378a-3p/VEGFA/RGC-32 Axis. Co-author DOI 10.1002/cam4.70446 ↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Shuyan Liu · 1 shared paper, 2026
- Paper Prognostic and Immunological Value of CTNNB1 in Pancreatic Adenocarcinoma: A Comprehensive NGS and Multicomponent Analy… DOI 10.1155/genr/8700258 ↗
Liang Zhu · 1 shared paper, 2024
- Paper Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating miR-378a-3p/VEGFA/RGC-32 Axis. DOI 10.1002/cam4.70446 ↗
Jinli He · 1 shared paper, 2024
- Paper Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating miR-378a-3p/VEGFA/RGC-32 Axis. DOI 10.1002/cam4.70446 ↗
Xiaojing Ren · 1 shared paper, 2025
- Paper REG3A secreted by peritumoral acinar cells enhances pancreatic ductal adenocarcinoma progression via activation of EGFR… DOI 10.1186/s12964-025-02103-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.